B7‐H3 promotes acute and chronic allograft rejection
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The B7 homolog B7‐H3 is important for the regulation of immune responses though its functions in vivo are controversial. We report the first clinical and experimental data concerning expression and function of B7‐H3 in alloresponses. Immunohistological and molecular analyses showed B7‐H3 expression by cells mediating rejection of human and mouse allografts. To analyze the significance of B7‐H3 in rejecting allografts, we generated B7‐H3 –/– mice and showed that targeting of B7‐H3 was synergistic with other forms of immune modulation; e.g. a regimen of rapamycin gave 12–14 days of survival in wild‐type controls but led to permanent cardiac and islet allograft survival in B7‐H3 –/– mice. Cardiac allografts in treated B7‐H3 –/– mice showed markedly decreased production of key cytokine, chemokine and chemokine receptor mRNA transcripts as compared to wild‐type controls. The incidence of chronic rejection in two different cardiac allograft models was also inhibited in B7‐H3 –/– as compared to wild‐type recipients. Lastly, in addition to the expected antigen‐presenting cell expression of B7‐H3, CD4 and CD8 T cells showed B7‐H3 induction upon cell activation, and both dendritic cell‐ and T cell‐expressed B7‐H3 each enhanced T cell proliferation in vitro and in vivo . We conclude that B7‐H3 promotes T cell‐mediated immune responses and the development of acute and chronic allograft rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses
Suh, W.-K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S., Bukczynski, J., Plyte, S., Elia, A., et al. (2003) · Nature Immunology · doi:10.1038/ni967 · Cited by 576
Murine B7-H3 is a negative regulator of T cells
Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., & Dong, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2500 · Cited by 368
Cited by
Deacetylase inhibition promotes the generation and function of regulatory T cells
Tao, R., de Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., et al. (2007) · Nature Medicine · doi:10.1038/nm1652 · Cited by 924
Self-citationMolecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Picarda, E., Ohaegbulam, K. C., & Zang, X. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2428 · Cited by 582
“org Clin Cancer Res; 22(14) July 15, 2016 3427”
BackgroundInfluentialCoinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Schildberg, F. A., Klein, S. R., Freeman, G. J., & Sharpe, A. H. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.002 · Cited by 542
Senescence-Associated Exosome Release from Human Prostate Cancer Cells
Lehmann, B. D., Paine, M. S., Brooks, A. M., McCubrey, J. A., Renegar, R. H., Wang, R., & Terrian, D. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6538 · Cited by 464
B7-H3: An Attractive Target for Antibody-based Immunotherapy
Kontos, F., Michelakos, T., Kurokawa, T., Sadagopan, A., Schwab, J. H., Ferrone, C. R., & Ferrone, S. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2584 · Cited by 389
Metadata
- Authors
- Wang, L., Fraser, C. C., Kikly, K., Wells, A. D., Han, R., Coyle, A. J., Chen, L., & Hancock, W. W.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2005-01-28
- Volume
- 35
- Issue
- 2
- Pages
- 428-438
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2050791058
- Cited by
- 102
- References
- 3
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: B7‐H3 promotes acute and chronic allograft rejection. https://app.cochat.ai/papers/10.1002/eji.200425518
- The paper
- Wang, L., Fraser, C. C., Kikly, K., Wells, A. D., Han, R., Coyle, A. J., Chen, L., & Hancock, W. W. (2005). B7‐H3 promotes acute and chronic allograft rejection. European Journal of Immunology. https://doi.org/10.1002/eji.200425518
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.